SAN ANTONIO, Oct. 16, 2025 /PRNewswire/ — SmartAlpha announced its collaboration with GE HealthCare to commercialize Nerveblox™, the company’s initial AI solution designed to assist ultrasound-guided regional anesthesia. The technology met with U.S. anesthesiologists for the first time at the annual meeting of the American Society of Anesthesiologists (ASA) in San Antonio, as integrated software within GE HealthCare’s Venue™ family of point-of-care ultrasound systems.
The collaboration combines SmartAlpha’s expertise in procedural ultrasound AI with GE HealthCare’s point-of-care ultrasound platforms, bringing real-time anatomical recognition and visual assistance directly into procedural workflows at scale. It aligns directly with SmartAlpha’s mission of simplifying and expanding the use of ultrasound with AI to support clinicians globally in delivering more accessible care.
Nerveblox offers broad anatomical coverage, recognizing over 50 anatomical structures across 12 of the most common nerve block procedures. It is designed to provide real-time assistance during scanning to aid clinicians in interpreting ultrasound images and supports the broader goal of making ultrasound guidance more accessible across care settings.
“GE HealthCare’s point-of-care ultrasound systems have long been trusted worldwide, and we are pleased that our technology will now reach clinics globally through these systems, where market access has been granted,” said Utku Kaya, Co-founder and CEO of SmartAlpha. “This collaboration allows SmartAlpha’s AI to be commercialized and deployed at scale, empowering clinicians with AI and enhancing how ultrasound is used at the point of care.”
“Our ultrasound portfolio is continuously evolving to meet the dynamic needs of clinicians, and we’re committed to driving innovation that makes our solutions more versatile, adaptable, and impactful,” said Karley Yoder, CEO of Comprehensive Care Ultrasound, Advanced Visualization Solutions at GE HealthCare. “With the latest Venue family systems, we’re proud to add new tools that enhance the use of POCUS in anesthesiology and pain management and enhance other tools and features that empower clinicians across all experience levels to deliver confident care anytime, anywhere.”
For more information, visit: https://www.gehealthcare.com/products/ultrasound/venue-family/venue-family-innovation.
With Nerveblox as its initial commercialization, SmartAlpha’s technology continues to expand to address the moments when ultrasound users need assistance the most, specifically driven by clinical skill needs, quality of care requirements, and the growing demand for care accessibility across healthcare systems.
About SmartAlpha
SmartAlpha, headquartered in Türkiye with operations in the U.S. and Europe, is dedicated to expanding the use of ultrasound by delivering advanced medical skills through clinically proven and regulatory-cleared AI. The company operates with a team of engineers and clinical specialists, working in close collaboration with world-renowned physicians, and partners with leading global medical imaging vendors through whom its products are distributed to markets worldwide.
Disclaimer
Nerveblox is not available for sale in all regions. In regions where Nerveblox is commercially available, it is intended solely for use by qualified healthcare professionals who are licensed to perform ultrasound-guided regional anesthesia procedures and have been trained in the use of the software, in accordance with local regulations.
SOURCE SmartAlpha
